Rare Dedication

Two words to encapsulate the core principles of an entire company.

Sigma-Tau Pharmaceuticals, Inc. is a rare corporation dedicated to creating novel therapies for the unmet needs of patients with rare diseases. Truly unique in its field, Sigma-Tau places its considerable scientific resources behind the discovery of compounds that benefit the few. Simply because it's the right thing to do.

By maintaining an environment based on integrity, honesty, and placing the patient first, Sigma-Tau is able to consider what may be a small commercial success nothing less than a human triumph. To us, there is no greater accomplishment than helping the little girl who is suffering from corneal cystinosis or the man with Hodgkin's lymphoma.

After all, to Sigma-Tau, there's no difference between a disease that affects 300 or 300,000,000.

Gregg Lapointe
Chief Operating Officer
Sigma-Tau Pharmaceuticals, Inc.

A Message from Our COO

Our core belief is that no patient should go untreated simply because the disease they are fighting is so rare that only a few thousand, or even a few hundred, people suffer from the condition.

Under the inspiring leadership of our founder, Dr. Claudio Cavazza, every one of us shares an unwavering commitment to develop novel products and therapies for these small numbers of patients. As you browse our Web site, you'll see this unique vision and our passion woven into everything we do.

From our people, to our pipeline, to our partners, and most importantly, to our patients, Sigma-Tau is dedicated to the relentless pursuit of creating treatments for rare diseases.